Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience

Rayner, LJA; Challapalli, A; Blackmore, E; Rea, K; Wells, N; White, P; Hilman, S; Masson, S; Huckett, R; Garadi, K; Garadi, K; Kirk, H; Kabala, J; Oikonomopoulou, V; Bahl, A

doi:10.1200/JCO.2018.36.6_suppl.328

Authors

LJA Rayner

A Challapalli

E Blackmore

K Rea

N Wells

Paul White Paul.White@uwe.ac.uk
Professor in Applied Statistics

S Hilman

S Masson

R Huckett

K Garadi

H Kirk

J Kabala

V Oikonomopoulou

A Bahl

Abstract

Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience

Citation

Rayner, L., Challapalli, A., Blackmore, E., Rea, K., Wells, N., White, P., …Bahl, A. (2018). Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience. Journal of Clinical Oncology, 36(6), 328. https://doi.org/10.1200/JCO.2018.36.6_suppl.328

Journal Article Type	Article
Acceptance Date	Feb 9, 2018
Online Publication Date	Feb 26, 2018
Publication Date	Feb 26, 2018
Deposit Date	Mar 9, 2018
Publicly Available Date	Aug 27, 2018
Journal	Journal of Clinical Oncology
Print ISSN	0732-183X
Publisher	American Society of Clinical Oncology
Peer Reviewed	Peer Reviewed
Volume	36
Issue	6
Pages	328
DOI	https://doi.org/10.1200/JCO.2018.36.6_suppl.328
Keywords	upfront, docetaxel, androgen deprivation therapy, elderly patient, metastatic hormone-naive prostate cancer, single institution experience
Public URL	https://uwe-repository.worktribe.com/output/875646
Publisher URL	http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.328
Related Public URLs	http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.6_suppl.328